Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries

SHANGHAI and MOSCOW, Dec. 20, 2022 /PRNewswire/ -- Mabwell Bioscience (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, today announced the company has entered into an licensing agreement with the Russian pharmaceutical company Binnopharm Group, for 9M...

2022-12-20 17:00 3187

Mentice AB (publ) receives an order of 1,1 million USD for simulation solutions from Beijing Huanya Zhitong on behalf of the Chinese Medical Education Association.

GOTHENBURG, Sweden, Dec. 20, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that Beijing Huanya Zhitong,Beijing, China, has signed an agreement to acquire Mentice VIST® simulation solutions for ...

2022-12-20 00:35 2118

Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination

Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer DUBLIN and FLORENCE, Italy, Dec. 19, 2022 /PRNewswire/ -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapie...

2022-12-19 23:07 3672

Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board

SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the Scientific Advisory Board. He joins Prof. Jianzhu Chen of theMassach...

2022-12-19 22:00 2966

Health and Hydrogen launches one of the first medical-grade Molecular Hydrogen Inhalation Machine HAH-301

GURGAON, India, Dec. 19, 2022 /PRNewswire/ -- Molecular Hydrogen Inhalation therapy is now extensively used for its many health benefits, such as reducing inflammation, improving cellular function, and protecting against oxidative stress.Health And Hydrogen rec...

2022-12-19 21:01 4968

Health and Hydrogen launches one of the first medical-grade Molecular Hydrogen Inhalation Machine HAH-301

SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit

First-of-its-kind one-for-all cancer mutation detection test SHENZHEN, China, Dec. 19, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for PanCanSeek® Cancer Mutation Detection Kit...

2022-12-19 21:00 2344

Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON

WUHAN, China and SAN DIEGO, Dec. 19, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth")today announced receiving the U.S. Food and Drug Administration (FDA) clearance of its investigational new drug (IND) application on the in-vivo gene replacement therapy NFS-02 (rAAV2-ND1), for the...

2022-12-19 21:00 2762

China and ASEAN Deepened Exchanges and Cooperation on Traditional Medicine

BEIJING, Dec. 19, 2022 /PRNewswire/ -- A report from CRIOnline: From December 11 to 13, the 7th China-ASEAN Forum on Traditional Medicine was held in Fangchenggang City,Guangxi, China. China-ASEAN Forum on Traditional Medicine is held every two years. With the theme of "Seizing RCEP Opportunitie...

2022-12-19 20:01 3629

GenFleet Therapeutics and Merck Enter into Trial Collaboration to Initiate Study Investigating Combination Therapy of GFH925 (KRAS G12C inhibitor) and ERBITUX® (cetuximab)

SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck to start a clinical study of...

2022-12-19 19:00 2065

Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives

--The issue date of the patent will be January 3, 2023 by the United States Patent and Trademark Office (USPTO). The patent number is 11,541,071 -- The issued patent covers ASC10 and its derivatives, and their uses to treat virus infections including SARS-CoV-2, monkeypox virus and respiratory s...

2022-12-19 18:10 4221

Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans

The prevalence of cardiovascular and oncology diseases and the shortage of radiologists have boosted the development of innovative MRI technologies SAN ANTONIO, Dec. 19, 2022 /PRNewswire/ -- The traditional magnetic resonance imaging (MRI) approach is being disrupted by portable MRI systems, open...

2022-12-19 16:12 2307

Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans

SmartFuture Launches First Responder Platform

SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- As a key addition to its portfolio of Remote Patient Monitoring (RPM) solutions, SmartFuture has launched a First Responder Platform. This is an integrated solution designed for rapid response through real time monitoring of health vitals, doctor consultat...

2022-12-19 16:09 2920

Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines

TAIZHOU, China, Dec. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received the clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, fr...

2022-12-19 13:53 4726

'NCDs in Focus Act Now' Summit organized by Viatris

The summit aimed to build synergies between healthcare professions and policy makers, addressing the challenges in the management of NCDs inSoutheast Asia BANGKOK, Dec. 19, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS): The 'NCDs in Focus Act Now' Summit was recently organised by global health...

2022-12-19 09:30 3304

TG ImmunoPharma (TGI) announces FDA clearance of IND application for TGI-2, a novel anti-PVRIG therapeutic antibody

HEFEI, China, Dec. 17, 2022 /PRNewswire/ -- TG ImmunoPharma Co., Ltd. (Hefei, China), an innovative biotech company dedicated to the discovery of novel immunotherapeutic drugs and a leader in NK cell research globally, today announced that the U.S. Food and Drug Administration (FDA) has cleared i...

2022-12-17 21:30 3280

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

* Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform * Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Gra...

2022-12-16 19:56 4425

Possible Breakthrough in Cardiovascular Disease Diagnostics for the United States

SINGAPORE, Dec. 16, 2022 /PRNewswire/ -- Neuome Peptides Pte. Ltd., a Singapore -based company has established an assay-developmentplatform, powered by machine learning and novel, patented algorithms for the quantifiable detection of biomarkers.

2022-12-16 16:04 2718

Possible Breakthrough in Cardiovascular Disease Diagnostics for the United States

Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia

2022-12-16 16:03 3668

CES 2023: OMRON Healthcare Introducing Initiatives to Advance Its Vision of "Going for Zero" -- Elimination of Heart Attack and Stroke

KYOTO, Japan, Dec. 16, 2022 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter the Company) will exhibit at CES 2023 (*), the world's largest consumer tech show taking place inLas Vegas from Thursday, January 5, through Sunday, January 8. At the show, the Company will showcase the innovative...

2022-12-16 16:00 4401

Novavax Announces Pricing of $65 Million Public Offering of Common Stock

GAITHERSBURG, Md., Dec. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an underwritten public offering to sell 6,500,000 shares of ...

2022-12-16 14:49 7231

1 ... 490 491 492493494 495 496 ... 643